UBS has given Nutrien a 'Neutral' rating and set a target price of $51 per share.
The analyst from the Swiss bank, Joshua Spector, mentioned that Nutrien's performance in the third quarter was in line with expectations but slightly below consensus estimates. The operating results were particularly weak, indicating challenges in that area. However, Nutrien is reportedly making progress in managing costs and investments, which could have a positive impact on future performance.
Nutrien's shares are currently priced at $48.94, with no change from the previous day. The stock has experienced a high of $60.85 and a low of $44.69 over the course of the year, reflecting market volatility.